Page 262 - Small Animal Internal Medicine, 6th Edition
P. 262

234    PART I   Cardiovascular System Disorders


            is external compression of the cranial cava, usually by a mass.   Heilmann RM, et al. Hyperhomocysteinemia in greyhounds and its
            Pleural effusion occurs commonly; the effusion is often   association with hyperfolatemia and other clinicopathologic
  VetBooks.ir  chylous because lymph flow from the thoracic duct into the   Hogan DF, et al. Antiplatelet effects and pharmacodynamics of
                                                                  variables. J Vet Intern Med. 2017;31:109–116.
            cranial vena cava also is impaired. Thrombosis that extends
                                                                  clopidogrel in cats. J Am Vet Med Assoc. 2004;225:1406–1411.
            into the jugular veins is palpable in some cases. Because vena
            caval obstruction reduces pulmonary blood flow and both   Hogan DF, et al. Secondary prevention of cardiogenic arterial
                                                                  thromboembolism in the cat: the double-blind, randomized,
            left heart and right heart filling, signs of poor cardiac output   positive-controlled feline arterial thromboembolism; clopidogrel
            are common.                                           vs. aspirin trial (FAT CAT). J Vet Cardiol. 2015;17:S306–S317.
              Diagnosis of venous thrombosis is confirmed using   Kidd L, Stepien RL, Amrheiw DP. Clinical findings and coro-
            ultrasound or contrast imaging (angiography or CT with   nary artery disease in dogs and cats with acute and subacute
            contrast). Vena caval thrombosis might be visible on echo-  myocardial necrosis: 28 cases. J Am Anim Hosp Assoc. 2000;36:
            cardiogram, especially when the clot extends into the RA.   199–208.
            Thrombosis of the portal vein or caudal vena cava can be   Kidd L, Mackman N. Prothrombotic mechanisms and anticoagu-
            documented on abdominal ultrasound. Computer tomogra-  lant therapy in dogs with immune-mediated hemolytic anemia.
            phy with contrast can allow imaging of multiple body areas   J Vet Emerg Crit Care (San Antonio). 2013;23:3013.
            to demonstrate thrombosis (luminal masses within vessels   Lake-Bakaar GA,  Johnson EG,  Griffiths  LG. Aortic  thrombosis
                                                                  in dogs: 31 cases (2000-2010). J Am Vet Med Assoc. 2012;241:
            with associated filling defects).                     910–915.
              Clinicopathologic findings generally reflect underlying   Laurenson MP, et al. Concurrent diseases and conditions in dogs
            disease and tissue damage resulting from vascular obstruc-  with splenic vein thrombosis. J Vet Intern Med. 2010;24:1298–1304.
            tion. Cranial caval thrombosis has been associated with   Licari LG, Kovacic JP. Thrombin physiology and pathophysiology.
            thrombocytopenia. Management is as discussed earlier for   J Vet Emerg Crit Care (San Antonio). 2009;19:11–22.
            arterial thrombosis,  with an  emphasis on  anticoagulants   Mellett AM, Nakamura RK, Bianco D. A prospective study of clopi-
            rather than antiplatelet drugs because of the low shear condi-  dogrel therapy in dogs with primary immune-mediated hemo-
            tions in the venous system. Stenting of the affected vessel is   lytic anemia. J Vet Intern Med. 2011;25:71–75.
            another therapeutic option.                          Moore KE, et al. Retrospective study of streptokinase administra-
                                                                  tion in 46 cats with arterial thromboembolism. J Vet Emerg Crit
                                                                  Care (San Antonio). 2000;10:245–257.
            Suggested Readings                                   Morassi A, et al. Evaluation of the safety and tolerability of rivar-
            Alwood AJ, et al. Anticoagulant effects of low-molecular–weight   oxaban in dogs with presumed primary immune-mediated
              heparins in healthy cats. J Vet Intern Med. 2007;21:378–387.  hemolytic anemia. J Vet Emerg Crit Care (San Antonio). 2016;26:
            Bedard C, Lanevschi-Pietersma A, Dunn M. Evaluation of coagula-  488–494.
              tion markers in the plasma of healthy cats and cats with asymp-  Myers JA, et al. Pharmacokinetics and pharmacodynamics of the
              tomatic hypertrophic cardiomyopathy. Vet Clin Pathol. 2007;36:   factor Xa inhibitor apixaban after oral and intravenous adminis-
              167–172.                                            tration to cats. Am J Vet Res. 2015;76:732–738.
            Borgeat K, et al. Arterial thromboembolism in 250 cats in general   Nelson OL, Andreasen C. The utility of plasma D-dimer to identify
              practice: 2004-2012. J Vet Intern Med. 2014;28:102–108.  thromboembolic disease in dogs.  J  Vet  Intern  Med. 2003;17:
            Boswood A, Lamb CR, White RN. Aortic and iliac thrombosis in   830–834.
              six dogs. J Small Anim Pract. 2000;41:109–114.     Olsen LH, et al. Increased platelet aggregation response in Cavalier
            Bright JM, Dowers K, Powers BE. Effects of the glycoprotein IIb/  King Charles Spaniels with mitral valve prolapse.  J Vet Intern
              IIIa antagonist abciximab on thrombus formation and platelet   Med. 2001;15:209–216.
              function in cats with arterial injury. Vet Ther. 2003;4:35–46.  Ralph AG, et al. Spontaneous echocardiographic contrast in three
            Carr AP, Panciera DL, Kidd L. Prognostic factors for mortality and   dogs. J Vet Emerg Crit Care (San Antonio). 2011;21:158–165.
              thromboembolism in canine immune-mediated hemolytic   Respess M, et al. Portal vein thrombosis in 33 dogs: 1998-2011. J
              anemia: a retrospective study of 72 dogs. J Vet Intern Med. 2002;   Vet Intern Med. 2012;26:230–237.
              16:504–509.                                        Schermerhorn TS, Pembleton-Corbett JR, Kornreich B. Pulmonary
            De Laforcade AM, et al. Hemostatic changes in dogs with naturally   thromboembolism in cats. J Vet Intern Med. 2004;18:533–535.
              occurring sepsis. J Vet Intern Med. 2003;17:674–679.  Smith CE, et al. Use of low molecular weight heparin in cats: 57
            Goncalves R, et al. Clinical and neurological characteristics of   cases (1999-2003). J Am Vet Med Assoc. 2004;225:1237–1241.
              aortic thromboembolism in dogs. J Small Anim Pract. 2008;49:   Smith SA. The cell-based model of coagulation. J Vet Emerg Crit
              178–184.                                            Care (San Antonio). 2009;19:3–10.
            Good LI, Manning AM. Thromboembolic disease: physiology of   Smith SA, et al. Arterial thromboembolism in cats: acute crisis in
              hemostasis and pathophysiology of thrombosis. Compend Contin   127 cases (1992-2001) and long-term management with low-
              Educ Pract Vet. 2003;25:650–658.                    dose aspirin in 24 cases. J Vet Intern Med. 2003;17:73–83.
            Good LI, Manning AM. Thromboembolic disease: predispositions   Smith SA, Tobias AH. Feline arterial thromboembolism: an update.
              and clinical management.  Compend Contin Educ Pract Vet.   Vet Clin North Am Small Anim Pract. 2004;34:1245–1271.
              2003;25:660–674.                                   Stokol T, et al. D-dimer concentrations in healthy dogs and dogs
            Goodwin JC, Hogan DF, Green HW. The pharmacodynamics of   with disseminated intravascular coagulation.  Am J Vet Res.
              clopidogrel in the dog. J Vet Intern Med. 2007;21:609.  2000;61:393–398.
            Goodwin LV, et al. Hypercoagulability in dogs with protein-losing   Stokol T, et al. Hypercoagulability in cats with cardiomyopathy. J
              enteropathy. J Vet Intern Med. 2011;25:273–277.     Vet Intern Med. 2008;22:546–552.
   257   258   259   260   261   262   263   264   265   266   267